Teoxane
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Teoxane sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Teoxane: 10 sponsored US clinical trials, none currently recruiting.
Teoxane sponsors 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. The most-studied condition in this pipeline is Nasolabial Folds, Wrinkles, with 1 trials.
Top-decile sponsor footprint
Teoxane ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
10 total, page 1 of 1
RHA® Redensity With New Anesthetic Agent Perioral Rhytids (PAS)
NCT06378086
RHA®4 for Midface Volume Deficiency
NCT05133739
RHA® 4 NLF Cannula
NCT04754646
RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows
NCT04577898
RHA® 3 Versus Restylane-L® for Lip Augmentation
NCT04540913
RHA® Redensity With New Anesthetic Agent - Perioral Rhytids
NCT04069585
RHA® 4 With New Anesthetic - Nasolabial Folds
NCT04087395
RHA Redensity - Perioral Rhytids
NCT03092219
TEOSYAL® RHA Ultra Deep and Perlane-L® for the Correction of Nasolabial Folds
NCT02253147
TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines, and Juvéderm® Ultra XC for the Correction of Nasolabial Folds
NCT02195427
Therapeutic Areas
How the Teoxane archive is shaped
10 indexed studies, none listed as recruiting (0% open); 9 completed (90%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Nasolabial Folds, Wrinkles (1 trial), 4 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Teoxane: archived-pipeline peers nationwide
Peers matched on 10 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Teoxane sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 archived trials
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Teoxane page
10 registered trials is a research-attention snapshot, not an endorsement of Teoxane or any single study.
- None of Teoxane's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Nasolabial Folds, Wrinkles is the condition Teoxane studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Nasolabial Folds, Wrinkles trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Teoxane pipeline card: 10 registered trials from official public datasets.Report a data error.